Belinostat (Compound)

Synonyms:Belinostat, 414864-00-9, PXD101, Belinostat (PXD101), 866323-14-0, Beleodaq, PXD-101, (E)-N-hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide, NSC726630, N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE, PX-105684, PX105684, (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide, NSC-726630, F4H96P17NZ, PXD 101, CHEBI:61076, N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE, 2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-, (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide, (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide, N-hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide, 2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-, (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide., E-Belinostat, 2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-, (2E)-, Belinostat [USAN], Belinostat [USAN:INN], N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide, UNII-F4H96P17NZ, (2E)-N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-2-PROPENAMIDE, PXD101;PX105684, Belinostat Ph3, Beleodaq (TN), N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide, BELINOSTAT [MI], Belinostat - PXD101, BELINOSTAT [INN], Belinostat (USAN/INN), BELINOSTAT [VANDF], N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide, BELINOSTAT [WHO-DD], N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide, MLS006011091, CHEMBL408513, GTPL7496, BELINOSTAT [ORANGE BOOK], BDBM25150, CHEBI:94531, AMY1792, DTXSID60194378, EX-A180, (E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid, BCPP000351, BCP01741, Belinostat,PXD101, PX105684, MFCD08064035, NSC758774, s1085, AKOS025401741, BCP9000386, CCG-208758, DB05015, NSC-758774, NCGC00263155-02, NCGC00263155-05, AC-25046, AC-35365, AS-17068, SMR004702879, B5888, SW219445-1, EC-000.2286, A25012, D08870, EN300-7361191, J-523584, Q4882925, BRD-K17743125-001-01-9, N-Hydroxy-3-[(phenylamino)sulfonyl]-trans-cinnamamide, (E)-N-Hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, 5OG

Pubchem:PUBCHEM:6918638

Id:9e460725-8b1f-567f-b150-7c8832859ddb

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Belinostat's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Belinostat.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Belinostat.

Results found

Linked to

	Label	Description
	BRD-K17743125-001-08-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 04876 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04876; PubChem_CID:6918638, FILE=drugcentral_drug_04876.json)
	belinostat (465b2ca0-6d17-4f08-bda9-2f38be0d5f14) Collection (Entity type)	Metadatata for belinostat
	Belinostat bioactivity Histone deacetylase 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Belinostat negatively regulates NFKBIA Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Belinostat negatively regulates APOBEC3B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Belinostat positively regulates ALDOC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Belinostat negatively regulates SERPINF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Belinostat negatively regulates EPCAM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Belinostat bioactivity Histone deacetylase 6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG